The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TRITON2: An international, multicenter, open-label, phase II study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD).
 
Wassim Abida
Honoraria - CARET
Consulting or Advisory Role - Clovis Oncology
Research Funding - AstraZeneca; Clovis Oncology; GlaxoSmithKline (Inst); Zenith Epigenetics
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Alan Haruo Bryce
No Relationships to Disclose
 
Arjun Vasant Balar
Honoraria - Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Cerulean Pharma; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Merck (Inst)
 
Gurkamal S. Chatta
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - BMS and Astra Zeneca
 
Nancy Ann Dawson
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Eisai; Exelixis; Genentech/Roche; Janssen Biotech; Merck; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Janssen Scientific Affairs
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Eisai; Exelixis; Genentech/Roche; Janssen Biotech; Merck; Novartis; Pfizer; Sanofi
Research Funding - Acceleron Pharma (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Pfizer (Inst); Roche/Genentech (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Elizabeth A. Guancial
Honoraria - UroToday
Consulting or Advisory Role - Genentech/Roche
Speakers' Bureau - Genentech/Roche
 
Arif Hussain
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Novartis
Research Funding - Agensys; Bayer; Cerulean Pharma; Clovis Oncology; Merck; Sotio
 
Gautam Gopalji Jha
No Relationships to Disclose
 
David Uri Lipsitz
No Relationships to Disclose
 
Akash Patnaik
No Relationships to Disclose
 
Daniel Peter Petrylak
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; TYME
Consulting or Advisory Role - Bayer; Bellicum Pharmaceuticals; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Pfizer; Roche; Sanofi; TYME
Research Funding - Agensys; Astellas Medivation; AstraZeneca; Bayer; Dendreon; Endocyte; Genentech; Innocrin Pharma; Johnson & Johnson; Lilly; MedImmune; Merck; Millennium; Novartis; Oncogenex; Pfizer; Progenics; Roche; Sanofi; Sotio
Expert Testimony - Celgene; sanofi
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis
 
Thomas S. Stanton
No Relationships to Disclose
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Pfizer; UpToDate
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Caris Life Sciences; Fujifilm; Genentech/Roche; HERON; Pfizer; Tolero Pharmaceuticals
Speakers' Bureau - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Sanofi
Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; US Oncology
 
Jingsong Zhang
Consulting or Advisory Role - AstraZeneca; Sanofi
Speakers' Bureau - AstraZeneca; Sanofi
Research Funding - Astellas Pharma; AstraZeneca; Bayer
 
Andrew Simmons
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
Consulting or Advisory Role - Redwood Bioscience
 
Jowell Go
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Tony Golsorkhi
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Simon Chowdhury
Honoraria - GlaxoSmithKline; Novartis
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Janssen; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Clovis Oncology; Janssen; Pfizer; Sanofi
Research Funding - Johnson & Johnson; Sanofi
 
Howard I. Scher
Leadership - Asterias Biotherapeutics
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Ferring; Janssen Research & Development; Merck; Onclive; Physicans' Education Resource; Sanofi; WIRB-Copernicus Group
Research Funding - Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Asterias Biotherapeutics; Ferring; Onclive; Physicans' Education Resource; WIRB-Copernicus Group